Articles tagged with Immune System
A Tel Aviv University study challenges the widely-held assumption that COVID-19 originated from bats, instead highlighting their highly effective immune system. The researchers found that many reported findings on bat-borne viruses are based on antibody presence or PCR tests rather than actual virus isolation.
A study published in The Lancet Rheumatology found that booster vaccinations significantly increase immune protection for individuals with autoimmune diseases such as rheumatism and inflammatory bowel disease. Most patients experienced no significant side effects after receiving a third vaccination, and their antibodies effectively pro...
Researchers found that combining BCL-2 inhibitors can selectively eliminate senescent cells, improving efficacy and reducing toxicity by targeting high-MCL-1 expressing subpopulation of cells. This synergistic approach enables lower doses of drugs to be used, overcoming resistance to monotherapy.
A study by LSU found that elite student-athletes could safely return to practice and play football after COVID-19 isolation, with their immune system returning to baseline levels. This contrasts with older adults with comorbidities, who are at higher risk for serious side effects.
Researchers at LSU Health New Orleans have identified a critical immunosuppressive pathway and developed an experimental inhibitor to protect T-cells from weakening. The CBL-B inhibitors show great potential in enhancing the efficacy of cancer immunotherapy, making patients' T-cells more effective in killing cancer cells.
Researchers have found that human antibodies can incorporate foreign genetic material from the mitochondria and ends of chromosomes, leading to increased immune diversity. This discovery challenges the long-held assumption that antibody diversity results solely from gene mutations.
Researchers have discovered the key components in plant cells that trigger 'wartime' protein production in response to pathogens. This mechanism allows plants to rapidly produce defense proteins while balancing resources between growth and defense, a delicate process that could inform strategies for creating disease-resistant crops.
Scientists at the University of Bonn discovered that an overactivated cGAS/STING signaling pathway leads to severe inflammation in ANCA-associated vasculitis. The study involved patients with the disease and a novel mouse model, providing new insights into potential drug targets.
Researchers at RCSI found that patients with Long COVID syndrome have a blood-clotting imbalance due to high levels of von Willebrand Factor and low levels of ADAMTS13. The study suggests that this imbalance contributes to symptoms such as shortness of breath and fatigue.
A new study identifies PDIA3 as a molecule targeted by the immune system in response to stress, contributing to liver damage in type 2 diabetes and obesity. Elevated levels of antibodies for PDIA3 have been found in people with these conditions, but improving diet and weight can reverse this liver condition.
Research suggests rising temperatures could disrupt sleep patterns and blunt the immune response, making people more susceptible to infections. This is particularly concerning for low-income communities and communities of color who face heightened risks from heat and limited access to air conditioning.
Researchers captured first image of antigen-bound T-cell receptor complex with bound antigen at atomic resolution. The study reveals no significant structural changes in the receptor after antigen binding, sparking further investigation into the signaling pathway activation mechanism.
Researchers at Cedars-Sinai Medical Center have developed a new method to identify which human gut microbes contribute to inflammatory diseases. By analyzing protein levels in blood serum, the team discovered specific bacteria that trigger immune activation and inflammation.
A study published in Frontiers in Immunology found that Japanese herbal medicine DKT reduces colitis severity by preventing gut bacteria loss and increasing immune cells. It restores Lactobacillus levels and promotes type 3 innate lymphoid cells, alleviating inflammatory responses.
Researchers found that immune cells prefer nutrient fuels previously thought to be waste products, including lactate. This discovery could lead to personalized dietary recommendations to supercharge the immune system. The findings also suggest a strong influence of nutrients on T cell function and survival.
A new study led by Marc Veldhoen found that tissue resident white blood cells use glucose as an energy source and have a faster metabolism than circulating lymphocytes. This discovery highlights the importance of having a balanced diet for a healthy immune response.
A new study reveals that certain food proteins can cause white blood cells to become dysfunctional, leading to immune intolerance. Researchers found that the gut-associated-lymphoid tissue is a suppressive environment where lymphocytes undergo arrested development, preventing dangerous immune reactions to food.
A recent international study has shed light on the inner workings of the adaptive immune response, revealing how killer T cells recognize viral invaders using molecular road signs. The study highlights the crucial role of chaperones in ensuring the stability and longevity of these road signs, allowing for more effective detection and d...
New research reveals that social rejection can drive individuals to prioritize disease protection. When people experience social pain, they become more likely to take concerted efforts to safeguard against COVID-19. Conversely, when social interactions are less painful, people may be less vigilant in protecting themselves.
Scientists have discovered a new way to detect infection by sensing physical forces produced by bacterial invasion. Cells use mechanosensor protein PIEZO1 to detect changes in surface tension, triggering an early and fast immune response.
Researchers developed nanoparticles to deliver anti-inflammatory payloads directly to inflamed blood vessels, significantly increasing survival chances and delaying rupture onset. Targeting specific NF-kappaB subunits improved therapeutic effects with fewer adverse effects.
Researchers at the University of Pittsburgh have discovered that even terminally exhausted T cells retain some capacity to function again. They identified approaches to overcome exhaustion by targeting co-stimulation pathways and reprogramming T cells to be resistant to hypoxia, a common tumor microenvironmental signal.
A new study has shown that the TB vaccine can produce a long-lasting 'trained immunity response' in infants, lasting more than 14 months after vaccination. The research found that the BCG vaccine's off-target effects on the immune system can lead to reprogramming of genes in a specific blood cell type, known as monocytes.
Researchers found that higher suPAR levels were associated with increased risk of blood clot formation in COVID-19 patients. Combining suPAR and D-dimer may improve predicting who is at high or low risk of blood clots, enabling targeted therapies to prevent critical outcomes.
Scientists discover guanylate-binding proteins that can directly kill specific types of bacteria, offering new treatment options for drug-resistant infections. These proteins can also be used in combination with existing antibiotics to enhance treatment effectiveness.
Researchers have created a comprehensive map of the human immune system, showing how immune cells communicate with each other. The map could lead to new immunotherapies for treating cancer, infectious diseases, and autoimmune conditions.
A new study reveals that air pollution and maternal stress during pregnancy can lead to altered brain development and social behavior in male mice, exhibiting autism-like traits. In contrast, female mice are not affected by these environmental factors.
Researchers at TIBI developed a minimally invasive method for targeted delivery of immunotherapeutic treatments, resulting in slower tumor growth and higher activation of T-cells. The injectable gelatin biomaterial containing silicate nanoplatelets showed sustained drug release and controlled ICI delivery.
A study reveals that an ADAR1 gene mutation activates ZBP1 protein, leading to programmed cell death and inflammatory responses. This causes damage to organs like the kidneys and liver in genetically modified mouse models.
A novel subset of CD8+ regulatory-like T cells (CD8+TRLs) has been identified as 'first responders' to stroke, providing fast-acting and lasting protection. These cells reach the brain within 24 hours after stroke onset, releasing molecules that provide direct neuroprotective effects.
Scientists at La Jolla Institute for Immunology discover how gut barrier cells send secret messages to patrolling T cells, keeping them alive and active. The study sheds light on conditions like inflammatory bowel disease and highlights the importance of HVEM protein in maintaining a healthy gut microbiome.
Researchers found that COVID-19 patients produce fewer ketone bodies than influenza patients, leading to reduced immune function. A ketogenic diet or administering ketone bodies revived immune cells in diseased mice, improving virus elimination and lung damage.
Researchers at the University of Copenhagen have developed a new method to detect biliary tract cancer and other serious cancers by analyzing changes in microRNA molecules in patient blood. This approach enables early diagnosis and has potential for targeted treatments.
A team of researchers connected the dots for one important gut bacterium, revealing its molecular structure and function in the immune system. The study found that Akkermansia muciniphila's lipid activates toll-like receptors, triggering the release of certain cytokines while leaving others alone.
A third COVID-19 booster helped identify and neutralize 20 different variants, reducing the risk of breakthrough infections and severe disease. The study provides valuable insights into the immune system's response to new variants and informs strategies for managing the pandemic.
A new study from Tel Aviv University found that CRISPR therapeutics can lead to a significant loss of genetic material in treated cells, potentially destabilizing the genome and promoting cancer. The researchers detected up to 10% of cells with lost chromosomes, highlighting the need for extra care when using this technology.
Researchers at Max Delbrück Center for Molecular Medicine found that silencing the EBAG9 gene in CAR T cells increases their effectiveness and reduces side effects. This breakthrough could lead to a new therapy approach for blood cancer patients.
Researchers found that mothers who didn't transmit HCMV to their infants had higher levels of antibody-dependent cellular phagocytosis, suggesting a non-neutralizing immunity mechanism. This finding has implications for the development of effective HCMV vaccines.
A study by Goethe University Frankfurt found that antibodies against Omicron variants BA.1 and BA.2 decline rapidly, even after a second vaccination or booster shot, offering limited protection against infection.
Researchers have developed a novel COVID-19 vaccine based on altered plasmid DNA that effectively blocks cell infection across all tested variants. The vaccine targets a specific vulnerability in the SARS-CoV-2 virus's spike protein, inducing a focused antibody response.
Researchers at the Institut Pasteur and CNRS studied SARS-CoV-2 replication in bat cells, finding that viral infection triggers a powerful immune response that prevents the virus from replicating. The study uses real-time imaging techniques to visualize the speed of cell infection and the formation of syncytia.
Researchers at the University of South Australia have discovered that combining anti-rejection medication with immune checkpoint inhibitors can significantly reduce the risk of organ rejection and eliminate cancer cells in a quarter of patients. The study involved 22 patients with renal transplants and incurable locally advanced or met...
Researchers analyze delta variant's biophysical characteristics, revealing unique traits that evade neutralizing antibodies and contribute to severe symptoms. The study sheds light on why vaccinated individuals can still contract the virus and why delta variant hospitalizations are higher than other variants.
Researchers found that men who lose their Y chromosome as they age are more likely to experience deadly heart scarring and earlier death. The study suggests an existing drug may help counteract the effects of this loss, potentially leading to longer, healthier lives for affected men.
The SARS-Arena program identifies conserved peptides in the SARS-CoV-2 virus that could be used to develop vaccines. The peptides are part of the nucleocapsid protein, which is highly expressed upon infection and highly immunogenic.
Researchers found that breastfeeding provides an immune boost to infants, reducing the risk of respiratory infections such as pneumonia. However, milk also mounts responses to beneficial gut bacteria, which can be disruptive and increase the risk of gastrointestinal infections.
Scientists have uncovered how the innate immune system detects HIV-1, even at very small amounts, and activates a two-step molecular strategy to combat the virus. This discovery could lead to new methods for treating HIV and vaccines, as well as insights into other diseases like Alzheimer's.
Researchers propose a theory on how SARS-CoV-2 infects the body, leading to hyperactivation of the immune system and post-COVID syndromes. The hypothesis suggests that molecular motifs on the spike protein interact with immune cells, causing an overreaction and mistakenly attacking organs.
New research reveals that specific proteins in plant cells explain why plant defenses falter under high temperatures, leaving them susceptible to infections. Scientists have also discovered a way to reverse this effect by constantly activating the CBP60g master switch gene, which bolsters plant defenses without stunting growth.
Researchers at the University of Chicago have made a breakthrough in understanding the development of type 1 diabetes by targeting the role of pancreatic beta cells. Deleting a gene called Alox15 in mice preserved their beta cells, reduced immune T cell infiltration, and prevented diabetes from developing.
Researchers at Gladstone Institutes and Stanford University identified key genes linked to T cell exhaustion. They discovered how to block these genes, resulting in healthier T cells and smaller tumors in mice with cancer. This breakthrough may lead to improved immune-based treatments for cancer patients.
A new study from UTHealth Houston found that flu vaccination was associated with a 40% lower risk of developing Alzheimer’s disease in US adults over a four-year period. The study analyzed a large sample of patients and found that consistent flu vaccination every year had the strongest protective effect.
A new study reveals that COVID-19 variants are formed in chronic patients with weakened immune systems, who experience prolonged infections. This leads to the accumulation of mutations, similar to those found in severe illness variants.
A Phase II study published in Frontiers in Oncology found that daily use of AHCC supplementation may help most patients eliminate their HPV infection and decrease the risk of HPV-related cancers. The study showed that 14 of 22 patients (63.6%) became HPV-negative, suggesting a potential treatment option for persistent HPV infections.
Researchers analyzed data from over 1.3 million patients and found females experience ear, nose, and throat issues, mood disorders, and fatigue, while males are more likely to suffer from renal disorders. Sex-disaggregated research is crucial for effective therapies and public health interventions.
Scientists have discovered a new, high-resolution view of the rabies virus glycoprotein, which could lead to more effective vaccines. The study's findings suggest that a better-shaped vaccine could provide lifelong protection against the deadly disease.
A new study published in iScience found that the co-development of the gut microbiome, immune system, and respiratory system is correlated with a baby's respiratory health. Disruption of any of these systems resulted in greater respiratory morbidity for infants, highlighting the importance of timing in intervening with therapies.
Researchers at Kyoto University identified the mechanism behind active inflammation and immunosuppression in tumor microenvironments. EP2/EP4 inhibitors suppress tumor growth by allowing regulatory T cells to infiltrate and activate within tumors, benefiting patients with certain cancers.
Researchers discuss Hepatitis D's life cycle and interactions with its host, exploring strategies for further research to combat this overlooked virus. HDV coinfects people with hepatitis B, rapidly progressing to liver cirrhosis and cancer if left untreated, with a review published in the Chinese Medical Journal.
A study from Cincinnati Children's Hospital Medical Center found that early antibiotic use disrupts the developing immune system of newborns, increasing risks of severe pneumonia and life-long health issues. Fecal transplants may offer a solution to mitigate these effects.